Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Economic and Financial Impacts of Cancer
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the economic burden and financial impact of cancer treatment, including the concept of financial toxicity, out-of-pocket costs, healthcare expenditure, cost communication, and drug pricing. It addresses the challenges related to the cost of care, financial hardship experienced by patients, and the implications for both patients and healthcare systems.
256
Works
IDs:OpenAlex
How has Economic and Financial Impacts of Cancer's publication output changed over time?
ScholarIQpublication output · 2011–2023
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2023.
1
1
1
1
3
1
2
2
1
1
2011201220132014201520162018201920222023
What are the most-cited papers on Economic and Financial Impacts of Cancer?
ScholarIQmost cited works
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Laura A. Levit, Erin P. Balogh, Sharyl J. Nass, Patricia A. Ganz
2014965 Citations
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins, Courtney Tyne, Douglas W. Blayney, Diane Blum, Adam P. Dicker, Patricia A. Ganz, J. Russell Hoverman, Robert M. Langdon, Gary H. Lyman, Neal J. Meropol, Therese M. Mulvey, Lee N. Newcomer, Jeffrey Peppercorn, Blasé N. Polite, Derek Raghavan, Gregory Rossi, Leonard B. Saltz, Deborah Schrag, Thomas J. Smith, Peter Paul Yu, Clifford A. Hudis, Richard L. Schilsky
Journal of Clinical Oncology. 2015911 Citations
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
Simiao Chen, Zhong Cao, Klaus Prettner, Michael Kühn, Juntao Yang, Lirui Jiao, Zhuoran Wang, Weimin Li, Pascal Geldsetzer, Till Bärnighausen, David E. Bloom, Chen Wang
JAMA Oncology. 2023860 CitationsOPEN ACCESS
Delivering affordable cancer care in high-income countries
Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro
The Lancet Oncology. 2011715 Citations
Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors
K. Robin Yabroff, Emily C. Dowling, Gery P. Guy, Matthew P. Banegas, Amy J. Davidoff, Xuesong Han, Katherine S. Virgo, Timothy S. McNeel, Neetu Chawla, Danielle Blanch‐Hartigan, Erin E. Kent, Chunyu Li, Juan J. Llibre Rodríguez, Janet S. de Moor, Zhiyuan Zheng, Ahmedin Jemal, Donatus U. Ekwueme
Journal of Clinical Oncology. 2015536 Citations
Where is Economic and Financial Impacts of Cancer research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Economic and Financial Impacts of Cancer is open access?
ScholarIQopen access share
40%OPEN ACCESS
Gold
7%
Green
13%
Hybrid
13%
Bronze
7%
Closed
60%
Related on ScholarIQ
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
Paper
Cancer treatment and survivorship statistics, 2019
Paper
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
Paper
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Paper
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Paper
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Paper